M&A Deal Summary

Lupin Acquires Nanomi B.V.

On January 30, 2014, Lupin acquired life science company Nanomi B.V.

Acquisition Highlights
  • This is Lupin’s 2nd transaction in the Life Science sector.
  • This is Lupin’s 1st transaction in the Netherlands.

M&A Deal Summary

Date 2014-01-30
Target Nanomi B.V.
Sector Life Science
Buyer(s) Lupin
Deal Type Add-on Acquisition

Target

Nanomi B.V.

Oldenzaal, Netherlands
Nanomi B.V. is a drug delivery company that develops pharmaceutical products based on nano- and microparticles. Nanomi targets business-to-business partnerships with pharma and biotech companies.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Lupin

Mumbai, India

Category Company
Founded 1968
Sector Life Science
Employees24,006
Revenue 221.9B INR (2025)
DESCRIPTION

Lupin is an innovation-led transnational pharmaceutical company producing and developing a wide range of branded & generic formulations, APIs and biotechnology products. Lupin was founded in 1968 and is based in Mumbai, Maharashtra.


DEAL STATS #
Overall 2 of 11
Sector: Life Science M&A 2 of 9
Type: Add-on Acquisition M&A Deals 1 of 7
Country: Netherlands M&A 1 of 1
Year: 2014 M&A 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2007-10-01 Kyowa Pharmaceutical

Osaka, Japan

Kyowa Pharmaceutical is a generic pharmaceutical company and is the domestic provider in the Central Nervous System (CNS) therapeutic area. Kyowa Pharmaceutical was founded in 1954 and is based in Osaka, Japan.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2014-09-30 Laboratorios Grin S.A. de C.V.

Mexico City, Mexico

Laboratorios Grin S.A. de C.V. is a specialty pharmaceutical company engaged in the development, manufacturing & commercialization of branded Ophthalmic products.

Buy -